MedBodh Clinical Series | 26 October 2026
Inhaled short-acting beta-2 agonists such as salbutamol are used for rapid bronchodilation during asthma exacerbations. Delivery device, severity, patient age and monitoring affect treatment.
Quick Note Sheet
Topic: Drug / Emergency Respiratory
Audience: doctors, nursing teams and healthcare administrators.
Safety: verify current local protocols, medicine formulation and patient-specific requirements.
When salbutamol is used
Acute wheeze and airflow obstruction consistent with asthma may respond to inhaled salbutamol. Assess severity, oxygen saturation, ability to speak, respiratory effort and danger signs; do not delay emergency escalation for severe attacks.
Nebulized dosing context
Common acute-care adult protocols use 2.5–5 mg per nebulized treatment, repeated according to severity and local emergency pathways. Paediatric regimens vary by age, weight and guideline; many protocols use 2.5 mg for smaller children and 5 mg for larger children. These are context-dependent examples, not universal prescriptions.
Preparation and concentration checks
Nebulizer solutions may be supplied as unit-dose nebules or concentrates of different strengths. Calculate the drug amount from the actual mg/mL or mg per nebule label. Dilute concentrates only with the manufacturer’s specified compatible solution and volume; do not assume every unit-dose product requires dilution.
Nebulizer versus spacer
For many mild-to-moderate attacks, a pressurized metered-dose inhaler with spacer is an effective alternative and may be preferred under local guidelines. Severe or life-threatening attacks require protocol-based emergency treatment and monitoring.
Adverse effects and monitoring
Monitor heart rate, tremor, clinical response and oxygenation. Repeated high-dose beta-agonists can contribute to hypokalaemia and lactic acidosis; monitor electrolytes and clinical course when indicated.
Escalation
Poor response, exhaustion, altered consciousness, silent chest or worsening hypoxia require urgent senior review and escalation. Salbutamol is not a substitute for systemic corticosteroids when indicated or for emergency respiratory support.
Practical checklist
- Verify identity, clinical or administrative indication and urgency.
- Review the applicable protocol and available resources.
- Document actions, communication and reassessment.
- Escalate discrepancies and red flags promptly.
Frequently asked questions
Does this replace a hospital protocol?
No. The responsible clinician or administrator must follow current official procedures.
Can the examples be applied without review?
No. They require clinical context, product verification and local authorization.
Reference
https://ginasthma.org/reports/
Educational content only; not an individualized prescription or administrative order.